The company plans to submit authorization filing to the US FDA before Thanksgiving, Pfizer CEO Albert Bourla said.

Emerging patterns suggest Moderna's two-dose vaccine might have a slight edge over Pfizer's in the long run.

Add Yahoo as a preferred source to see more of our stories on Google. A vial of the Pfizer/BioNTech Comirnaty vaccine against Covid-19 at a mass vaccination center on July 1, 2021 in Leipzig, Germany.

In Australia, the official advice is that the booster shot should be an mRNA vaccine - either Pfizer or Moderna. The ...

Japan has granted fast-track approval to U.S. drug maker Pfizer Inc.’s COVID-19 pill, the heath minister said Thursday, as ...

WASHINGTON — Pfizer and Moderna say the Food and Drug Administration have opened up COVID-19 booster shots to all adults, letting them choose another dose of either vaccine. The move expands the ...

Pfizer's CEO confirmed on Twitter that they seek emergency use authorization to provide a second COVID-19 booster shot for adults 65 years and older. Albert Bourla said that they submitted the ...

On Tuesday, the Centers for Disease Control and Prevention updated recommendations for booster shots, saying that people who got the Pfizer vaccine should now seek out a booster shot five months after ...

Here’s what we’ve learned – and how our understanding has evolved – since the earliest cases of the novel coronavirus were ...